Search research articles
Contact Us
Filters
Showing results (131-140 of 151) with videos related to
Page
of 16
Sort By:
The Journal of Urology
|
June 25, 2017
Real-Time Changes in Brain Activity during Sacral Neuromodulation for Overactive Bladder
Bradley C Gill, Javier Pizarro-Berdichevsky, Pallab K Bhattacharyya, et al.
Breast Cancer Research and Treatment
|
November 21, 2025
Adverse effects of scalp cooling for the reduction of chemotherapy-induced alopecia: A systematic review and meta-analysis
Caitlin A Kearney, Anna L Brinks, Carli D Needle, et al.
Research in Human Development
|
January 29, 2024
APPLYING THE LIFESPAN MODEL OF ETHNIC-RACIAL IDENTITY: EXPLORING AFFECT, BEHAVIOR, AND COGNITION TO PROMOTE WELL-BEING
Amy K Marks, Esther Calzada, Lisa Kiang, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
July 13, 2007
Unintentional exposure of neonates to conventional radiography in the Neonatal Intensive Care Units
D Bader, H Datz, G Bartal, et al.
Melanoma Research
|
May 8, 2020
Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec
Claire Audrey-Bayan, Megan H Trager, Robyn D Gartrell-Corrado, et al.
Cancer Investigation
|
June 2, 2021
Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin
Douglas K Marks, John Kucharczyk, Pan Kim, et al.
Current Oncology Reports
|
November 15, 2018
Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma
Claire-Audrey Y Bayan, Adriana T Lopez, Robyn D Gartrell, et al.
Current Oncology Reports
|
August 27, 2018
The Role of Oncolytic Viruses in the Treatment of Melanoma
Claire-Audrey Y Bayan, Adriana T Lopez, Robyn D Gartrell, et al.
Frontiers in Oncology
|
July 3, 2020
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
Douglas K Marks, Robyn D Gartrell, Margueritta El Asmar, et al.
Clinical Breast Cancer
|
May 24, 2022
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer
Rami S Vanguri, Kathleen M Fenn, Matthew R Kearney, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 151) with videos related to
Sort By:
Page
of 16
The Journal of Urology
|
June 25, 2017
Real-Time Changes in Brain Activity during Sacral Neuromodulation for Overactive Bladder
Bradley C Gill, Javier Pizarro-Berdichevsky, Pallab K Bhattacharyya, et al.
Breast Cancer Research and Treatment
|
November 21, 2025
Adverse effects of scalp cooling for the reduction of chemotherapy-induced alopecia: A systematic review and meta-analysis
Caitlin A Kearney, Anna L Brinks, Carli D Needle, et al.
Research in Human Development
|
January 29, 2024
APPLYING THE LIFESPAN MODEL OF ETHNIC-RACIAL IDENTITY: EXPLORING AFFECT, BEHAVIOR, AND COGNITION TO PROMOTE WELL-BEING
Amy K Marks, Esther Calzada, Lisa Kiang, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
July 13, 2007
Unintentional exposure of neonates to conventional radiography in the Neonatal Intensive Care Units
D Bader, H Datz, G Bartal, et al.
Melanoma Research
|
May 8, 2020
Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec
Claire Audrey-Bayan, Megan H Trager, Robyn D Gartrell-Corrado, et al.
Cancer Investigation
|
June 2, 2021
Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin
Douglas K Marks, John Kucharczyk, Pan Kim, et al.
Current Oncology Reports
|
November 15, 2018
Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma
Claire-Audrey Y Bayan, Adriana T Lopez, Robyn D Gartrell, et al.
Current Oncology Reports
|
August 27, 2018
The Role of Oncolytic Viruses in the Treatment of Melanoma
Claire-Audrey Y Bayan, Adriana T Lopez, Robyn D Gartrell, et al.
Frontiers in Oncology
|
July 3, 2020
Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer
Douglas K Marks, Robyn D Gartrell, Margueritta El Asmar, et al.
Clinical Breast Cancer
|
May 24, 2022
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer
Rami S Vanguri, Kathleen M Fenn, Matthew R Kearney, et al.
Page
of 16